-
ILCSC Session Highlight: Integrative Oncology and the Use of Complementary and Alternative Medicine Approaches in the Management of Lung Cancer
The International Lung Cancer Survivorship Conference (ILCSC) is bringing the world's leading lung cancer experts directly to you! Today's speaker spotlight highlights Dr. Gabriel Lopez (MD Anderson...
IN THE SPOTLIGHT
-
ILCSC Session Highlight: Addressing Brain Mets in Lung Cancer
Leading lung cancer expert Dr. Manmeet Ahluwalia (Miami Cancer Institute) discusses brain metastases in people living with lung cancer. Register for free for the virtual... -
Decentralized Trials: Bringing Clinical Trials Closer to the Patient
While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to... -
Research Progress in SCLC Opens Doors to New Treatment Opportunities
Findings from a recent scientific study looking at a large number of small cell lung cancer (SCLC) patient specimens have the potential to change the way we diagnose and treat SCLC... -
LUNGevity's International Lung Cancer Survivorship Conference
LUNGevity's 2023 International Lung Cancer Survivorship Conference features something for everyone! Our lineup of internationally renowned lung cancer experts will be covering a... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to connect with others who share common experiences and build your community. Register in advance for this... -
2023 ASCO: Highlights of Lung Cancer Research
Recently, members of LUNGevity Foundation joined thousands of attendees from the US and around the world, including oncologists, scientists, biotech and pharmaceutical... -
Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care
Join us for a discussion on lung cancer biomarkers to learn what biomarker testing is, why it’s important, and how it can be used to optimize your treatment plans. We are thrilled... -
Tracing the Clues of a Global Killer: How Dr. Charles Swanton’s Research Is Shedding New Light on Lung Cancer
As Chief Investigator of the groundbreaking Cancer Research UK (CRUK) TRACERx study, you could say that Dr. Charles Swanton is having a moment. Launched nine years ago, TRACERx... -
The Basics of Neuroendocrine Tumors (NETs)
Our lung tissue is made of different kinds of cells, including neuroendocrine cells. If these cells develop changes in their genome, they can begin to grow out of control and...
How Nina’s Clinical Trial Led to a High-Five Celebration
How Nina’s Clinical Trial Led to a High-Five Celebration
Her doctor was excited, which made Nina excited. They high-fived and couldn’t believe the progress that had been made in just a few weeks. The clinical trial was already having positive effects. Before her clinical trial success, Nina went through the standard treatments for people with small-cell lung cancer (SCLC). She was diagnosed in early 2014, and the plan was to try different chemo and radiation therapies.But, after 14 months of treatment with side-effects, it became clear the standard…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
One Patient's SCLC Journey
One Patient's SCLC Journey
Learn about small cell lung cancer through the eyes of a patient and his oncologist. Dr. Christine Lovly, internationally recognized medical oncologist, and Jeff Lackey, an SCLC survivor, discuss their journey, the importance of lung cancer screening, and key considerations when someone is newly diagnosed.
This session is moderated by Amy Moore, PhD, LUNGevity's Vice President of Global Engagement and Patient Partnerships. Christine M. Lovly, MD, PhD, is Associate Professor of Medicine and co…